CVB Share Price Performance
CVB Community Fair Values
- AU$0.18FV52.8% undervalued intrinsic discount86.30%Revenue growth p.a.0users have liked this narrative0users have commented on this narrative3users have followed this narrative9 days ago author updated this narrative
Recent CVB News & Updates
No updates
CurveBeam AI Limited Key Details
Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.05
- Gross Margin
- 43.69%
- Net Profit Margin
- -246.09%
- Debt/Equity Ratio
- 38.1%
CurveBeam AI Limited Competitors
About CVB
- Founded
- 2009
- Employees
- n/a
- CEO
- WebsiteView website
CurveBeam AI Limited engages in the development and manufacture of point-of care specialized weight bearing medical imaging equipment in Europe and North America. The company builds artificial intelligence tools to aid in bone separation and segmentation, empowering orthopedic surgeons to make 3D-based deformity measurements to inform clinical decisions. It is also involved in AI’s Deep Learning AI based platform aids in bone microstructure analysis. The company’s target customers include orthopedic practices, imaging centers, and hospitals. CurveBeam AI Limited was incorporated in 2009 and is headquartered in Hatfield, Pennsylvania.
U.S. Market Performance
- 7 Days: -0.6%
- 3 Months: 11.8%
- 1 Year: 16.8%
- Year to Date: 7.5%
Over the last 7 days, the market has remained flat, although notably the Healthcare sector declined by 4.2%. Meanwhile, the market is actually up 17% over the past year. Earnings are forecast to grow by 15% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading